Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pregabalin for treating paroxysmal painful symptoms in multiple sclerosis: a pilot study.

Literature DB >> 19579001

Pregabalin for treating paroxysmal painful symptoms in multiple sclerosis: a pilot study.

Claudio Solaro, Margit Boehmker, Paolo Tanganelli.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2009 PMID： 19579001 DOI： 10.1007/s00415-009-5203-6

Source DB: PubMed Journal: J Neurol ISSN： 0340-5354 Impact factor: 4.849

× No keyword cloud information.

7 in total

1. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial.

Authors: H Lesser; U Sharma; L LaMoreaux; R M Poole
Journal: Neurology Date: 2004-12-14 Impact factor: 9.910

2. Antiepileptic medications in multiple sclerosis: adverse effects in a three-year follow-up study.

Authors: C Solaro; G Brichetto; M A Battaglia; M Messmer Uccelli; G L Mancardi
Journal: Neurol Sci Date: 2005-02 Impact factor: 3.307

3. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial.

Authors: R H Dworkin; A E Corbin; J P Young; U Sharma; L LaMoreaux; H Bockbrader; E A Garofalo; R M Poole
Journal: Neurology Date: 2003-04-22 Impact factor: 9.910

4. An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients.

Authors: C Solaro; G L Lunardi; E Capello; M Inglese; M Messmer Uccelli; A Uccelli; G L Mancardi
Journal: Neurology Date: 1998-08 Impact factor: 9.910

Review 5. Pain associated with multiple sclerosis: systematic review and proposed classification.

Authors: Alec B O'Connor; Steven R Schwid; David N Herrmann; John D Markman; Robert H Dworkin
Journal: Pain Date: 2007-10-24 Impact factor: 6.961

6. The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study.

Authors: C Solaro; G Brichetto; M P Amato; E Cocco; B Colombo; G D'Aleo; C Gasperini; A Ghezzi; V Martinelli; C Milanese; F Patti; M Trojano; E Verdun; G L Mancardi
Journal: Neurology Date: 2004-09-14 Impact factor: 9.910

7. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures.

Authors: Santiago Arroyo; Henning Anhut; Alan R Kugler; Caroline M Lee; Lloyd E Knapp; Elizabeth A Garofalo; Silke Messmer
Journal: Epilepsia Date: 2004-01 Impact factor: 5.864

7 in total

11 in total

Review 10. Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models.

Authors: Nemat Khan; Maree T Smith
Journal: Inflammopharmacology Date: 2014-02 Impact factor: 4.473

Pregabalin for treating paroxysmal painful symptoms in multiple sclerosis: a pilot study.

1. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial.

2. Antiepileptic medications in multiple sclerosis: adverse effects in a three-year follow-up study.

3. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial.

4. An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients.

Review 5. Pain associated with multiple sclerosis: systematic review and proposed classification.

6. The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study.

7. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures.

Review 1. Pharmacological management of pain in patients with multiple sclerosis.

Review 2. Management of pain in multiple sclerosis: a pharmacological approach.

Review 3. Painful and involuntary multiple sclerosis.

Review 4. Role of cannabinoids in multiple sclerosis.

Review 5. Central Neuropathic Pain Syndromes: Current and Emerging Pharmacological Strategies.

Review 6. Pain and multiple sclerosis: pathophysiology and treatment.

Review 7. A systematic review of pharmacological pain management in multiple sclerosis.

8. Symptomatic therapy and rehabilitation in primary progressive multiple sclerosis.

Review 9. Current and Innovative Pharmacological Options to Treat Typical and Atypical Trigeminal Neuralgia.

Review 10. Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models.